Draw
|
Currency :
Structure Search
AG003AXC
797-63-7 | Levonorgestrel
AG003AXC
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
- mg
- g
- kg
- ml
- L
无数据
无数据
| CAS Number | 797-63-7 |
| Catalog Number | AG003AXC(AGN-PC-0UF80M) |
| Chemical Name | Levonorgestrel |
| IUPAC Name | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one |
| InChI | InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
| InChI Key | WWYNJERNGUHSAO-XUDSTZEESA-N |
| MDL Number | MFCD00199013 |
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.4458 |
| NSC Number | 744007 |
| SMILES | O=C1CC[C@]2([H])[C@@]3([H])CC[C@]4(CC)[C@@](C#C)(O)CC[C@@]4([H])[C@]3([H])CCC2=C1 |
| UNII | 5W7SIA7YZW |
| Synonyms | Capronor,
Cerazet,
D Norgestrel,
D-Norgestrel,
duofem,
l Norgestrel,
l-Norgestrel,
Levonorgestrel,
Microlut,
Microval,
Mirena,
Norgeston,
NorLevo,
Norplant,
Norplant 2,
Norplant-2,
Norplant2,
Plan B,
Vikela,
Levonorgestrel,
norgestrel,
797-63-7,
D-Norgestrel,
(-)-Norgestrel,
Levonova,
Microval,
Postinor,
Mirena,
Jadelle,
Neogest,
Ovrette,
Plan B,
NORPLANT,
Norplant 2,
Follistrel,
Microlution,
Microgyn,
Microlut,
Monovar,
Ovranette,
Triagynon,
Triciclor,
Trivora,
Nordet,
Trigoa,
18-Methylnorethisterone,
Levonorgestrelum,
Microgynon CD,
Microgest ED,
Norplant II,
Logynon ED,
Ovral-Lo,
Levlen ED,
Microgynon 21,
Microgynon 28,
Trinordiol 21,
Trinordiol 28,
d(-)-Norgestrel,
Minivlar 30,
Monofeme 28,
Neogynon 21,
Nordette 21,
Nordette 28,
Stediril 30,
Levonelle,
Trifeme 28,
Levlen,
Preven,
Microgynon 30 ED,
Tri-Levlen 21,
Levora-21,
Levora-28,
Rigevidon 21+7,
NorLevo,
Triquilar ED,
LO/Ovral,
Triphasil 21,
Triphasil 28,
LD norgestrel [French],
Levonorgestrelum [INN-Latin],
Norgestrelum [INN-Latin],
D-(-)-Norgestrel,
Nordette,
Levonorgestrel implants,
E-Gen-C,
Tri-Levlen,
6533-00-2,
Norgestrel [Progestins],
Ovoplex 30-150,
Methylnorethindrone,
FH 122-A,
Norgestrel-(-)-D,
Wy 3707,
Wy-3707,
Wy-5104,
UNII-5W7SIA7YZW,
17-Ethynyl-18-methyl-19-nortestosterone,
17alpha-Ethynyl-18-homo-19-nortestosterone,
Norplant System in Plastic Container,
Norgestrelum,
SH 850,
18-Methyl-17-alpha-ethynyl-19-nortestosterone,
dl-Norgestrel,
CCRIS 6525,
CCRIS 9033,
SH 70850,
HSDB 3595,
HSDB 6483,
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one,
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one,
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol,
17alpha-Ethynyl-13-ethyl-19-nortestosterone,
Levonorgestrel(Levonelle),
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one,
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one,
EINECS 212-349-8,
EINECS 229-433-5,
5W7SIA7YZW,
BRN 2391114,
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one,
18,19-Dinor-4-pregnen-20-yn-3-one,
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone,
MLS000069491,
CHEBI:6443,
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one,
19-Nortestosterone, 17-ethynyl-18-methyl-,
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one,
13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one,
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one,
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-,
MFCD00199013,
NCGC00159349-02,
Capronor,
Norgeston,
SMR000059117,
dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one,
alpha-Norgestrel,
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE,
17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one,
(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one,
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-,
Norplant-2,
DSSTox_CID_16496,
DSSTox_RID_79283,
DSSTox_GSID_36496,
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one,
Microluton,
Tetragynon,
Levogel,
Levosert,
Liletta,
Skyla,
13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one,
Next choice,
Fallback Solo,
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-,
Postinor-2,
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-,
Plan B One Step,
Plan B One-Step,
Norplant (TN),
Ovrette (TN),
Mirena (TN),
component of Lo/ovral,
Levonorgestrel (Levonelle),
Levonorgestrel [USAN:INN:BAN],
LNG-IUS,
Norgestrel [USAN:BAN:INN:JAN],
Norgestrel [USAN:INN:BAN:JAN],
72-HOURS,
Kyleena,
Levonorgestrel (JAN/USP/INN),
1lhv,
SOH-075,
Oral levonorgestrel,
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one,
CAS-797-63-7,
Prestwick_109,
(+-)-Norgestrel,
(-)-Levonorgestrel,
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one,
Levonorgestrel [USAN:USP:INN:BAN],
Levonorgestrel implant,
Skyla (TN),
BAY86-5028,
Norgestrel [USAN:USP:INN:BAN:JAN],
Levonorgestrel, 98%,
BAY 86-5028,
Opera_ID_552,
AC1Q6OEV,
Prestwick0_000773,
Prestwick1_000773,
Prestwick2_000773,
Prestwick3_000773,
Intrauterine levonorgestrel,
17alpha-Ethynyl-18-homo-19-nor-testosterone,
(-)-Norgestrel, 98%,
17-alpha-Ethynyl-13-ethyl-19-nortestosterone,
CHEMBL1389,
BIDD:PXR0194,
SCHEMBL27597,
BSPBio_000846,
MLS000759484,
MLS001074069,
MLS001423967,
SPBio_002785,
13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one,
AC1L211U,
BPBio1_000932,
GTPL2881,
Levonelle;D-Norgestrel;Levonova,
Norgestrel (JP17/USP/INN),
DTXSID3036496,
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one,
WWYNJERNGUHSAO-XUDSTZEESA-N,
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one,
HMS1570K08,
HMS2051M08,
HMS2090O06,
HMS2097K08,
HMS2232H06,
HMS2232K12,
HMS3649J10,
HMS3714K08,
(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one,
BCP21999,
HY-B0257,
ZINC3814395,
D-(-)-Norgestrel (Levonorgestrel),
Tox21_111593,
Tox21_202872,
Tox21_303658,
BDBM50410522,
LMST02030119,
NSC744007,
s1727,
SH-850,
D(-)-Norgestrel, analytical standard,
AKOS015894913,
Tox21_111593_1,
BCP9000852,
CCG-100853,
CS-2243,
DB00367,
MCULE-1283162506,
NC00103,
NSC-744007,
[18,(17.alpha.)-(-)-],
NCGC00159349-03,
NCGC00159349-05,
NCGC00257283-01,
NCGC00260418-01,
AJ-45701,
LS-62083,
LS-62084,
SH-70850,
SMR000653526,
AB0012485,
AB2000252,
FT-0658692,
N0889,
C08149,
C08153,
D00950,
D00954,
EN300-122613,
797L637,
A835065,
SR-01000759218,
SR-01000946725,
(-)-17alpha-Ethynyl-18-methyl-19-nortestosterone,
SR-01000759218-5,
SR-01000946725-1,
BRD-K35189033-001-03-0,
13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one,
Z1551429747,
13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one,
UNII-3J8Q1747Z2 component WWYNJERNGUHSAO-XUDSTZEESA-N,
(17?)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-yn-3-one,
13beta-Ethyl-17alpha-ethynyl-17 beta-hydroxygon-4-en-3-one,
13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one,
Levonorgestrel, British Pharmacopoeia (BP) Reference Standard,
Levonorgestrel, European Pharmacopoeia (EP) Reference Standard,
18,19-Dinor-13beta-ethyl-17 beta hydroxy-4-pregnen-20-yn-3-one,
18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one,
Levonorgestrel, United States Pharmacopeia (USP) Reference Standard,
(-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one,
[(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one,
[18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-,(17..)-(-)-],
18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+)-,
Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard,
Levonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material,
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one,
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name),
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one,
Ld norgestrel,
Ovral,
L-Norgestrel,
Seasonique,
Seasonale,
Triphasil,
Alesse,
dexnorgestrel,
duofem,
Climara Pro,
Microgynon,
Trinordiol,
Malloside,
Stediril,
Cerazet,
Logynon,
Vikela,
DNorgestrel,
Ovran,
Levonorgestrel?,
l Norgestrel,
D Norgestrel,
Mixture Name,
Norplant2,
D-Levonorgestrel,
DL Norgestrel,
DL-Levonorgestrel,
component of Ovral,
Triphasil-21,
CRYSELLE,
LEVLITE,
18-Methylnorethindrone,
TRIPHASIL-28,
LOW-OGESTREL-21,
LOW-OGESTREL-28,
ENPRESSE-21,
ENPRESSE-28,
NORDETTE-21,
NORDETTE-28,
LESSINA-21,
LESSINA-28,
TRIVORA-21,
TRIVORA-28,
AVIANE-21,
AVIANE-28,
D0A9MR,
D0BA9U,
D0G6CT,
PORTIA-21,
PORTIA-28,
LO/OVRAL-28,
OVRAL-28,
UNII-3J8Q1747Z2,
2,5,6-trichloronicotinic acid,
Norgestrel (JP15/USP/INN),
Levonorgestrel [USAN:BAN:INN],
Wy3707,
C21H28O2,
CID13109,
OGESTREL 0.5/50-21,
OGESTREL 0.5/50-28,
LEVORA 0.15/30-21,
LEVORA 0.15/30-28,
3J8Q1747Z2,
ACN-037297,
ACN-037302,
C21-H28-O2,
CS-O-01737,
CS-O-30682,
PREVEN EMERGENCY CONTRACEPTIVE KIT,
B1960,
L-4455,
D009644,
D016912,
Levonelle, D-Norgestrel, Levonova, Levonorgestrel,
13-Ethyl-17alpha-ethynyl-17beta-hydroxy-4-gonen-3-one,
(+-)-13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one,
(+-)-17alpha-Ethynyl-13-ethyl-17-hydroxygon-4-en-3-one,
(+-)-17alpha-Ethynyl-13beta-ethylgon-4-en-17beta-ol-3-one,
dl-11beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one,
18,19-Dinor-17.alpha.-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-,
NOG,
(17-alpha)-(+-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one,
18,19-Dinor-17.Alfa.-pregn-4-en-20-yn-3-uno, 13-etil-17-hidroxi-, (+-)-(8CI),
18,19-Dinor-17.alpha.-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (.+.)-,
18,19-Dinorpregn-4-en-20-in-3-ona, 13-etil-17-hidroxi-, (17alfa )-(+-)-,
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-,
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-(.+.)-,
1819-Dinor-17alpha-pregn-4-en-20-yn-3-one 13-ethyl-17-hydroxy-(+-)-(8CI),
17489-40-6,
|
| Complexity | 609 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 6 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 312.209g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 312.453g/mol |
| Monoisotopic Mass | 312.209g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 37.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.3 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | 6.1 |
| Hazard statements | H351-H360 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P280-P308+P313 |
| UN Code | UN 2811 |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited